Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

John D. Carpten, Ph.D., a prominent genomics researcher and chief scientific officer at cancer research and treatment institution City of Hope, has these concerns.

Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes.

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samplesEntirely digital, AI-driven molecular ...

An experimental blood test for pancreatic cancer that was developed by Van Andel Institute and University of Pittsburgh ...

An FDA committee’s September 2024 vote to limit the use of Merck’s Keytruda and BMS’ Opdivo in stomach and esophageal cancers ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...

“A key objective of research focused on early-stage breast cancer is to identify biomarkers that can select patients who ...

TMB and various biomarkers were positively associated with improved pCR and EFS in high-risk, early-stage TNBC, regardless of ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward ...